Cargando…
Single-cell analysis reveals HBV-specific PD-1(+)CD8(+) TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
Immune checkpoint blockade (ICB) treatment of hepatocellular carcinoma (HCC) patients with hepatitis B virus (HBV) infection may activate viral-specific T cells to attack HBV infected hepatocytes and thus induce immune-related liver injury. Therefore, it is important to deeply understand the impacts...
Autores principales: | Liu, Lulu, Liu, Junwei, Li, Pan, Luo, Jijun, Qin, Rui, Peng, Qiao, Li, Bin, Wei, Xuyong, Wang, Tian, Shi, Hongyu, Wang, Ming-Da, Li, Chao, Fang, Weijia, Chen, Wei, Xu, Xiao, Yang, Tian, Yin, Weiwei, Zeng, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288678/ https://www.ncbi.nlm.nih.gov/pubmed/37353792 http://dx.doi.org/10.1186/s13046-023-02710-4 |
Ejemplares similares
-
Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023) -
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021) -
MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014) -
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
por: Shi, Jiawei, et al.
Publicado: (2022) -
HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)